Combination Therapy [topp]
rosuvastatin [orch, phsu]
fenofibric acid [orch, phsu]
Mixed [ftcn]
Dyslipidaemia [dsyn]
overview [inpr]
Efficacy [qlco]
Safety [hcpp]
Optimal [qlco]
Level [qlco]
Statin [orch, phsu]
therapy [ftcn]
Risk [qlco]
cardiovascular events [fndg]
majority [socb]
Dyslipidaemia [dsyn]
Patients [podg]
Patients [podg]
Mixed [ftcn]
Dyslipidaemia [dsyn]
Continued [idcn]
Elevation [topp]
Triglycerides [bacs, lipd]
Decreased HDL [fndg]
Residual [qlco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Patients [podg]
Multiple [qnco]
Abnormal [qlco]
Lipid [lipd]
Parameters [fndg]
Combination Drug Therapy [topp]
Lipid [lipd]
Current [tmco]
Guidelines [inpr]
recommend [idcn]
More [ftcn]
Goals [inpr]
High Risk [qlco]
Patients [podg]
Combination [qlco]
treatment [ftcn]
Agent [chvf]
Target [ftcn]
Triglycerides [bacs, lipd]
Patients [podg]
Mixed [ftcn]
Dyslipidaemia [dsyn]
Clinical Trials [resa]
rosuvastatin [orch, phsu]
fenofibric acid [orch, phsu]
Suggest [idcn]
Efficacy [qlco]
strategy [menp]
treatment [ftcn]
Mixed [ftcn]
Dyslipidaemia [dsyn]
